Cite
Dawwas GK, Hennessy S, Brensinger CM, et al. Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies. Clin Pharmacol Ther. 2021;111(1):227-242doi: 10.1002/cpt.2381.
Dawwas, G. K., Hennessy, S., Brensinger, C. M., Deo, R., Bilker, W. B., Soprano, S. E., Dhopeshwarkar, N., Flory, J. H., Bloomgarden, Z. T., Aquilante, C. L., Kimmel, S. E., & Leonard, C. E. (2022). Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies. Clinical pharmacology and therapeutics, 111(1), 227-242. https://doi.org/10.1002/cpt.2381
Dawwas, Ghadeer K, et al. "Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies." Clinical pharmacology and therapeutics vol. 111,1 (2022): 227-242. doi: https://doi.org/10.1002/cpt.2381
Dawwas GK, Hennessy S, Brensinger CM, Deo R, Bilker WB, Soprano SE, Dhopeshwarkar N, Flory JH, Bloomgarden ZT, Aquilante CL, Kimmel SE, Leonard CE. Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies. Clin Pharmacol Ther. 2022 Jan;111(1):227-242. doi: 10.1002/cpt.2381. Epub 2021 Aug 17. PMID: 34331322.
Copy
Download .nbib